Vijaya Diagnostic Centre Limited (NSE:VIJAYA)
India · Delayed Price · Currency is INR 946.70
-9.70 (-1.01%)
At close: Mar 9, 2026
Vijaya Diagnostic Centre Revenue
Vijaya Diagnostic Centre had revenue of 2.05B INR in the quarter ending December 31, 2025, with 21.44% growth. This brings the company's revenue in the last twelve months to 7.68B, up 15.79% year-over-year. In the fiscal year ending March 31, 2025, Vijaya Diagnostic Centre had annual revenue of 6.81B with 24.39% growth.
Revenue (ttm)
7.68B
Revenue Growth
+15.79%
P/S Ratio
12.68
Revenue / Employee
3.46M
Employees
2,218
Market Cap
97.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 6.81B | 1.34B | 24.39% |
| Mar 31, 2024 | 5.48B | 885.83M | 19.29% |
| Mar 31, 2023 | 4.59B | -31.47M | -0.68% |
| Mar 31, 2022 | 4.62B | 856.24M | 22.73% |
| Mar 31, 2021 | 3.77B | 379.25M | 11.19% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 568.09B |
| Cipla | 279.67B |
| Apollo Hospitals Enterprise | 242.15B |
| Divi's Laboratories | 103.14B |
| MedPlus Health Services | 65.38B |
| Indegene | 32.63B |
| Alivus Life Sciences | 25.12B |
| Metropolis Healthcare | 15.66B |